These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15068324)

  • 21. A biological staging model for operable non-small cell lung cancer.
    Cox G; Jones JL; Andi A; Waller DA; O'Byrne KJ
    Thorax; 2001 Jul; 56(7):561-6. PubMed ID: 11413356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR, HER-2 and COX-2 levels in colorectal cancer.
    Antonacopoulou AG; Tsamandas AC; Petsas T; Liava A; Scopa CD; Papavassiliou AG; Kalofonos HP
    Histopathology; 2008 Dec; 53(6):698-706. PubMed ID: 19102009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy.
    Richardson CM; Sharma RA; Cox G; O'Byrne KJ
    Lung Cancer; 2003 Jan; 39(1):1-13. PubMed ID: 12499088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Overexpression of COX-2 and its clinical significance in non-small cell lung cancer].
    Tian F; Wang TY; Gong M; Lu XM; Hu J; Wang J; Zhang CH
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):407-10. PubMed ID: 12895344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-expression of EGFR is closely correlated to poor prognosis in Tunisian patients with non-small cell lung adenocarcinoma.
    Arfaoui A; Kriaa L; Znaidi N; Gritli S; Bouacha H; Zermani R; Rammeh S
    J Immunoassay Immunochem; 2014; 35(3):256-68. PubMed ID: 24654822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival.
    Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P
    Cancer; 2002 May; 94(10):2669-74. PubMed ID: 12173335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.
    Achiwa H; Yatabe Y; Hida T; Kuroishi T; Kozaki K; Nakamura S; Ogawa M; Sugiura T; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1999 May; 5(5):1001-5. PubMed ID: 10353732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
    Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Mori K; Kurabe N; Kahyo T; Mori H; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2016 May; 7(22):32113-28. PubMed ID: 27050074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas.
    Araki K; Hashimoto K; Ardyanto TD; Osaki M; Shomori K; Nakamura H; Ito H
    Lung Cancer; 2004 Aug; 45(2):161-9. PubMed ID: 15246187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues 
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
    Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
    Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
    Ferrandina G; Ranelletti FO; Lauriola L; Fanfani F; Legge F; Mottolese M; Nicotra MR; Natali PG; Zakut VH; Scambia G
    Gynecol Oncol; 2002 May; 85(2):305-10. PubMed ID: 11972392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
    Onn A; Choe DH; Herbst RS; Correa AM; Munden RF; Truong MT; Vaporciyan AA; Isobe T; Gilcrease MZ; Marom EM
    Radiology; 2005 Oct; 237(1):342-7. PubMed ID: 16183941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer.
    Watkins DN; Lenzo JC; Segal A; Garlepp MJ; Thompson PJ
    Eur Respir J; 1999 Aug; 14(2):412-8. PubMed ID: 10515422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.
    Brooks KR; To K; Joshi MB; Conlon DH; Herndon JE; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2003 Jul; 76(1):187-93; discussion 193. PubMed ID: 12842538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.